Jill M. Broadfoot
2008 - Vical
In 2008, Jill M. Broadfoot earned a total compensation of $469K as Senior Vice President, Chief Financial Officer and Secretary at Vical.
Compensation breakdown
| Bonus | $80,000 |
|---|---|
| Option Awards | $69,701 |
| Salary | $284,000 |
| Stock Awards | $29,820 |
| Other | $5,523 |
| Total | $469,044 |
Broadfoot received $284K in salary, accounting for 61% of the total pay in 2008.
Broadfoot also received $80K in bonus, $69.7K in option awards, $29.8K in stock awards and $5.5K in other compensation.
Rankings
In 2008, Jill M. Broadfoot's compensation ranked 6,713th out of 9,135 executives tracked by ExecPay. In other words, Broadfoot earned more than 26.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,713 out of 9,135 | 27th |
Division Manufacturing | 2,496 out of 3,436 | 27th |
Major group Chemicals And Allied Products | 561 out of 815 | 31st |
Industry group Drugs | 391 out of 597 | 35th |
Industry Biological Products, Except Diagnostic Substances | 62 out of 118 | 48th |
Source: SEC filing on April 14, 2010.
Broadfoot's colleagues
We found two more compensation records of executives who worked with Jill M. Broadfoot at Vical in 2008.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019